Evidence map›Paper›PMID 30975896›Full record

ArticleThe Journal of experimental medicine2019

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients.

Maria A S Broggi, Lea Maillat, Cristina C Clement, Natacha Bordry, Patricia Corthésy, Aymeric Auger, Maurice Matter, Romain Hamelin, Lambert Potin, Davide Demurtas and 5 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Lymphatic transport in anti-tumor immunity and metastasis.The Journal of experimental medicine · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria A S BroggiInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland mas.broggi@gmail.com.ORCID 0000-0001-7909-5097
Lea MaillatInstitute for Molecular Engineering, University of Chicago, Chicago, IL.
Cristina C ClementDepartment of Pathology, Albert Einstein College of Medicine, New York, NY.
Natacha BordryClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne, Lausanne, Switzerland.
Patricia CorthésyInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Aymeric AugerDepartments of Surgery and Oncology, Lausanne University Hospital Center and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-0264-8818
Maurice MatterDepartments of Surgery and Oncology, Lausanne University Hospital Center and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1816-3003
Romain HamelinProteomics Core Facility, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Lambert PotinInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Davide DemurtasInterdisciplinary Centre for Electron Microscopy, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Emanuela RomanoTumor Immunobiology, Department of Oncology and Ludwig Cancer Research, University of Lausanne, Lausanne, Switzerland.
Alexandre HarariDepartments of Surgery and Oncology, Lausanne University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Daniel E SpeiserClinical Tumor Biology and Immunotherapy Group, Department of Oncology and Ludwig Cancer Research, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-2031-3250
Laura SantambrogioDepartment of Pathology, Albert Einstein College of Medicine, New York, NY.ORCID 0000-0002-4674-7041
Melody A SwartzInstitute of Bioengineering and Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland melodyswartz@uchicago.edu.ORCID 0000-0001-5484-1903

Funding

DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOMER01AI137198 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SANTAMBROGIO, LAURA, STERN, LAWRENCE J. · 2018 to 2022
$4.6M
Effects of Glycation and Carbonylation on MHC II-restricted immunityR01AI146180 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SANTAMBROGIO, LAURA, STERN, LAWRENCE J. · 2020 to 2024
$3.7M
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01R01CA219304 · NCI · UNIVERSITY OF CHICAGO · PI SWARTZ, MELODY ANN · 2018 to 2022
$1.8M
MHC class II-restricted immune response in immunosenescenceR01AG045223 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SANTAMBROGIO, LAURA · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA219304NIAID NIH HHS R01 AI137198NIAID NIH HHS R01 AI146180NIA NIH HHS R01 AG045223
6 · The paper itself

Abstract

Liquid biopsies allow monitoring of cancer progression and detection of relapse, but reliable biomarkers in melanoma are lacking. Because secreted factors preferentially drain to lymphatic vessels before dilution in the blood, we hypothesized that lymph should be vastly enriched in cancer biomarkers. We characterized postoperative lymphatic exudate and plasma of metastatic melanoma patients after lymphadenectomy and found a dramatic enrichment in lymphatic exudate of tumor-derived factors and especially extracellular vesicles containing melanoma-associated proteins and miRNAs, with unique protein signatures reflecting early versus advanced metastatic spread. Furthermore, lymphatic exudate was enriched in memory T cells, including tumor-reactive CD137

Indexed as

AnimalsBiomarkers, TumorCell Line, TumorCytokinesExosomesExtracellular VesiclesExudates and TransudatesHumansLymphLymphatic MetastasisLymphatic VesselsLymph Node ExcisionMelanomaMiceMice, Inbred C57BLMicroRNAsBiomarkers, TumorCytokinesMicroRNAsS100 Proteins

Identifiers

PMID30975896
PMCPMC6504224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.